Pulmonary fibrosis in Interstitial Lung Diseases v2.0

• Research type

  Research Study

• Full title

  Pathogenesis and Clinical Manifestations of Pulmonary Fibrosis in (A) Connective Tissue Diseases (CTD), (B) Granulomatous Conditions (GC), and (C) Idiopathic Interstitial Pneumonias (IIP)

• IRAS ID

  125496

• Contact name

  Athol U Wells

• Contact email

  athol.wells@rbht.nhs.uk

• Sponsor organisation

  Royal Brompton Hospital

• Research summary

  The principle research question is how genetic, immune and environmental factors interact to influence the development of lung fibrosis in (A) connective tissue diseases (CTD), (B) Granulomatous Conditions (GC), and (C) Idiopathic Interstitial Pneumonias (IIP). What are the critical genetic, biological and environmental components that can be used for the early identification of predisposition to lung fibrosis? The identification of these factors will also enhance our understanding of disease processes and may in future lead to the development of new therapies.

• REC name

  London - Dulwich Research Ethics Committee

• REC reference

  13/LO/0857

• Date of REC Opinion

  5 Sep 2013

• REC opinion

  Further Information Favourable Opinion